AU2104900A - Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine - Google Patents

Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine

Info

Publication number
AU2104900A
AU2104900A AU21049/00A AU2104900A AU2104900A AU 2104900 A AU2104900 A AU 2104900A AU 21049/00 A AU21049/00 A AU 21049/00A AU 2104900 A AU2104900 A AU 2104900A AU 2104900 A AU2104900 A AU 2104900A
Authority
AU
Australia
Prior art keywords
medicine
anaesthesia
same
composition used
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21049/00A
Inventor
Johan Huysman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2104900A publication Critical patent/AU2104900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU21049/00A 1998-12-23 1999-12-23 Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine Abandoned AU2104900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9816507 1998-12-23
FR9816507A FR2787713A1 (en) 1998-12-23 1998-12-23 COMPOSITION AS A MEDICINAL PRODUCT AND USE OF SUCH A COMPOSITION FOR OBTAINING A MEDICINAL PRODUCT FOR ANESTHESIA, ESPECIALLY ANALGESIC MEDICINAL PRODUCT
PCT/EP1999/010512 WO2000038678A1 (en) 1998-12-23 1999-12-23 Composition used as medicine and use of same for obtaining a medicine for anaesthesia, in particular analgesic medicine

Publications (1)

Publication Number Publication Date
AU2104900A true AU2104900A (en) 2000-07-31

Family

ID=9534561

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21049/00A Abandoned AU2104900A (en) 1998-12-23 1999-12-23 Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine

Country Status (3)

Country Link
AU (1) AU2104900A (en)
FR (1) FR2787713A1 (en)
WO (1) WO2000038678A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
JP2010522135A (en) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition
JP5714910B2 (en) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
BRPI1003620A2 (en) * 2010-09-03 2012-06-05 Ouro Fino Participacoes E Empreendimentos S A anesthetic combination, anesthetic composition, and veterinary anesthetic drug
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
FI128982B (en) 2016-05-09 2021-04-30 Vetcare Oy Compositions comprising mk-467 and psychoactive drug for use in sedation and/or anesthesia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
US5605911A (en) * 1995-01-31 1997-02-25 Washington University Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)

Also Published As

Publication number Publication date
WO2000038678A1 (en) 2000-07-06
FR2787713A1 (en) 2000-06-30

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
CA2274074A1 (en) Novel compounds with analgesic effect
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001257326A1 (en) Topical anesthetic/opioid formulations and uses thereof
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
AU2001231189A1 (en) Transdermal anesthetic and vasodilator composition and methods for topical administration
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
HUP0103851A3 (en) Factor viia inhibitors, process for their preparation, their use and pharmaceutical compositions comprising thereof
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
AU5326100A (en) Pharmaceutical compositions and methods for use
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
PL344246A1 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
AU5565099A (en) Pharmaceutical compositions and methods for use
AU1164601A (en) Therapeutic use and formulation
AU2905597A (en) Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
AU2003260241A1 (en) Buguzhi agent and composition and methods of preparing and administering the same
HK1035719A1 (en) Azabicyclic compounds, pharmaceutical composition containing them and their medicinal use
AU3638399A (en) Methods for preparation and use of tree injection nutrients and/or medicinal materials
AU2104900A (en) Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase